iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock outperforms market despite losses on the day | news.google.com • |
iBio, Inc. (NYSEAMERICAN:IBIO) Short Interest Update | news.google.com • |
iBio Inc. stock rises Friday, outperforms market | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-25 | 2024-06 | -0.46 | N/A | N/A | N/A |
2024-05-13 | 2024-03 | 0 | -0.71 | N/A | N/A |
2024-02-09 | 2023-12 | 0 | -2.42 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -4.2 | N/A | N/A |
2023-10-10 | 2023-06 | 0 | N/A | N/A | N/A |
2023-07-06 | 2023-03 | 0 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-31 | BRENNER MARTIN | Chief Executive Officer | 182.50K | Sale |
2014-09-16 | DESANTIS CARL R | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-03-30 | DURAN FELIPE | Chief Financial Officer | 39.63K | Stock Award(Grant) |
2020-08-10 | EASTERN CAPITAL LTD | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2020-06-03 | ERWIN ROBERT L | President | 108.11K | Sale |
2020-03-18 | ISETT THOMAS FRANCIS III | Chief Executive Officer | 1.27M | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 512.28K | 312.49K | 1.86% |
2023-06-29 | Avantax Planning Partners, Inc. | 155.00K | 94.55K | 0.56% |
2023-06-29 | Blackrock Inc. | 137.94K | 84.14K | 0.50% |
2023-06-29 | Bank Of New York Mellon Corporation | 87.47K | 53.36K | 0.32% |
2023-06-29 | Geode Capital Management, LLC | 76.29K | 46.53K | 0.28% |
2023-06-29 | Renaissance Technologies, LLC | 46.10K | 28.12K | 0.17% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 336.21K | 205.09K | 1.22% |
2023-06-29 | Vanguard Extended Market Index Fund | 165.75K | 101.11K | 0.60% |
2023-05-30 | Fidelity Extended Market Index Fund | 46.85K | 32.80K | 0.17% |
2023-05-30 | Fidelity Total Market Index Fund | 13.73K | 9.61K | 0.05% |
2023-05-30 | Fidelity Series Total Market Index Fund | 9.49K | 6.64K | 0.03% |
2023-06-29 | Vanguard Institutional Index-Inst Total Stock Market Ind | 7.28K | 4.44K | 0.03% |
Split | Date |
---|---|
1 : 20 | 2023-11-29 |
1 : 25 | 2022-10-10 |
1 : 10 | 2018-06-11 |
-
Thank you...! WE ARE ON THE RIGHT ONE $IBIO..!
-
Added... Holding for awhile on this.. Its coming home!
-
Is it true? 500 million allocated to $IBIO ? Confirm !
-
Wow should of invested more in INO
-
iBio Inc (NYSEAMERICAN: IBIO) has seen dramatic gains this month. While the stock is down about 4% thus far today on profit taking, theres a strong likelihood that we will see further gains ahead. At the end of the day, there are several catalysts around the corner that could send this stock to the moon.
-
Whats the forecast for eod price?
-
With supported PR.... Back to the 3$ territory $$$
-
-
Strong hold... Track the news.. It will see new highs $
-
Give these people a opportunity to get well $IBIO
-
Rainbow pattern forming, its about to blow!!
-
-
$IBIO will see gov $ to fast track research / cure!!!
-
Volume is juicy...! Fund money pouring in $$$$
-
Just allow us to average down...! Thank you $$$
-
$IBIO has DARPA funding for rapid pandemic response - it is part of the department of defense reaction plan for pandemic preparedness.
This is a pandemic. DARPA funded this company in order to respond to this precise scenario. Do your own DD and enjoy the ride.
Indicators like DARPA funding and CEPI grants are how to distinguish between legitimate runners like $MRNA $INO $IBIO and pumps. CEPI grants and DARPA funding vs noise.
-
$IBIO when will you figure out you’re being manipulated with premarket moves.
Do not sell this one under 3$ if you hold next week and not for less than 2.50$ before after hours today.
The volume alone will drive this for at least a week. Sadly, the virus is not going anywhere.
This is a single stranded RNA virus with at least TWO STRAINS requiring two or more vaccines:
Strain One is NCOV-SARS-2 (S)
Strain Two is NCOV-SARS-2 (L)
A third strain is suspected to have mutated in Iran and perhaps a fourth in Italy.
We already know someone can be reinfected and co-infected with a different strain after surviving. An American man in California was proven to have a co-infection of both the S and L strains. Japanese and Hong Kong scientists have reported casss of re-infection.
-
We hold.. because we know we can reach 3-4$ today
-
Securing our investment.. Bought 5,500 more!$$
-
Everyone here knows what we own... Its coming $$$
-
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock outperforms market despite losses on the day
news.google.com • -
iBio, Inc. (NYSEAMERICAN:IBIO) Short Interest Update
news.google.com • -
iBio Inc. stock rises Friday, outperforms market
news.google.com • -
iBio Inc. stock rises Thursday, still underperforms market
news.google.com •